The drug is still going through trials, but the medical company Lilly, behind it, is hopeful it can be rolled out soon. In ...

The results Lilly is reporting for its oral pill come as another big drug company, Pfizer, has decided to discontinue its ...

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...

Older adults living with Type 2 diabetes face more than just blood sugar concerns. New research shows some of the most ...

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

Imagine a world where managing type 2 diabetes doesn't involve needles. A new experimental pill might just change the game, ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The drug helped lower patients’ blood sugar and reduce their weight by an average of 16 pounds.

Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type ...

The mid-stage trial results announced by the pharmaceutical giant showed that patients taking orforglipron lost an average of ...

A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...